The Food and Drug Administration has approved an inactivated
Japanese encephalitis vaccine (JVax *) distributed by Connaught
Laboratories, Inc. (Swiftwater, Pennsylvania), for use by certain
travelers to and expatriates in Asia. Recommendations for vaccine
use are forthcoming from the Advisory Committee on Immunization
Practices.
Use of trade names and commercial sources is for identification
only and does not imply endorsement by the Public Health Service or
the U.S. Department of Health and Human Services.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
